Dr. David Feinberg spent much of a roughly 20-minute late morning session Monday talking about the potential benefits of EHRs, beyond competing for market share. But he was quick to defend the company in that regard as well.
Research of Johnson & Johnson's baby powder included a prison study in which inmates, mostly Black men, were injected with asbestos. The study was intended to assess how asbestos's effects on the skin compare to talc, the key component of baby powder.
Two biotechs are braving the roiling financial markets to raise money for clinical trials. AN2 Therapeutics is preparing for a pivotal test of its boron-based drug candidate for a rare, chronic lung disease. Okyo Pharma also filed IPO paperwork as it looks to advance to the clinic with its dry eye disease drug.
As we embrace breakthroughs in digital health, let's not cut, paste and proliferate the health equity issues of the offline world. We can only claim success when we measure who's engaging, who's not and why.
Getting patients to quit and remain tobacco-free requires ongoing treatment that's customized, flexible, easy to use, and free to the user. Primary care providers are well versed in the management of chronic, treatable conditions. It's time for primary care doctors to light the way toward getting patients to quit tobacco.
The FDA placed a partial clinical hold on a Phase 1 study testing experimental Alpine Immune Sciences cancer drug davoceticept in combination with Merck cancer immunotherapy Keytruda. The partial hold does not affect a separate study testing the Alpine drug as a monotherapy.
The director of psychological services at Amwell said that the report from the American Medical Association entitled "Accelerating and Enhancing Behavioral Health Integration Through Digitally Enabled Care: Opportunities and Challenges" represent a solid starting point for engaging multiple stakeholders in this effort.
By moving decisively to address waste, emissions and social inequality, organizations can turn sustainability into a competitive advantage. Here's how.
MedCity INVEST 2022 at The Ritz Carlton Chicago is a 3 day gathering with numerous opportunities for in-person networking and learning around the latest technologies and investment trends from VCs and successful entrepreneurs.
No comments